GOTHENBURG, SE / ACCESS Newswire / May 13, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) - Gothenburg, Sweden, May 13, ...

Factors Affecting the Growth of the Artificial Intelligence For Drug Development and Discovery Industry: ...

FDA Commissioner Marty Makary’s proposal to roll out a new drug approval pathway is heightening hope for the rare disease ...

Inductive Bio, a technology company democratizing artificial intelligence (AI) models to transform small molecule drug discovery, announced today that it has raised $25M in Series A financing led by ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

A $1.25 million investment is driving the development of a new treatment for advanced and therapy-resistant prostate cancer ...

Elliott is a very successful and astute activist investor. The firm's team includes analysts from leading tech private eq ...

Dimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.

Q1 2025 Earnings Call Transcript May 5, 2025 Certara, Inc. beats earnings expectations. Reported EPS is $0.14, expectations ...

Sustainability-by-design in bioprocess development, according to Adam Goldstein, senior director of R&D Collaborations at ...

At the intersection of radiation and precision, Novartis, Bayer, AstraZeneca and more hope to cash in on a ...